Table 2 Subtype assignment by selected characteristics.

From: CRF07_BC is associated with slow HIV disease progression in Chinese patients

Characteristic

B

C

01_AE

07_BC

08_BC

55_01B

Minor

URF

Total

n

%

n

%

n

%

n

%

n

%

n

%

n

%

n

%

n

%

Sex

Men

2217

12.93

79

0.46

8201

47.82

4762

27.77

104

0.61

425

2.48

361

2.1

1002

5.84

17,151

100

Women

266

25.17

33

3.12

284

26.87

323

30.56

55

5.2

8

0.76

53

5.01

35

3.31

1057

100

Age at diagnosis (years)

 < 18

33

36.67

3

3.33

20

22.22

26

28.89

1

1.11

1

1.11

3

3.33

3

3.33

90

100

18–24

222

10.63

10

0.48

987

47.27

661

31.66

12

0.57

31

1.48

40

1.92

125

5.99

2088

100

25–44

1246

15.02

50

0.6

3866

46.59

2225

26.81

87

1.05

117

1.41

167

2.01

540

6.51

8298

100

45–64

391

16.24

31

1.29

971

40.32

635

26.37

36

1.5

50

2.08

107

4.44

187

7.77

2408

100

 ≥ 65

44

13.25

5

1.51

111

33.43

114

34.34

11

3.31

5

1.51

13

3.92

29

8.73

332

100

Ethnicity

Han

1854

15.06

89

0.72

5734

46.56

3135

25.46

130

1.06

196

1.59

320

2.6

856

6.95

12,314

100

Uyghur

8

2.71

1

0.34

5

1.69

277

93.9

0

0

0

0

2

0.68

2

0.68

295

100

Yi

3

2.13

2

1.42

5

3.55

121

85.82

4

2.84

0

0

0

0

6

4.26

141

100

Others

73

15.21

7

1.46

218

45.42

132

27.5

13

2.71

8

1.67

8

1.67

21

4.38

480

100

Transmission risk groups

Heterosexual

735

15.36

133

2.78

2041

42.65

1088

22.74

207

4.33

76

1.59

190

3.97

315

6.58

4785

100

MSM

1640

12.01

39

0.29

6856

50.21

3672

26.89

39

0.29

372

2.72

254

1.86

783

5.73

13,655

100

Injecting drug user

63

3.97

80

5.05

161

10.16

1018

64.23

105

6.62

3

0.19

36

2.27

119

7.51

1585

100

Blood transfusion

378

82

0

0

41

8.89

31

6.72

3

0.65

0

0

7

1.52

1

0.22

461

100

Mother to child

15

50

1

3.33

6

20

3

10

2

6.67

0

0

3

10

0

0

30

100

Region

North

3460

47.46

1738

23.84

49

0.67

101

1.39

1198

16.43

57

0.78

201

2.76

486

6.67

7290

100

North-east

1211

55.7

460

21.16

15

0.69

21

0.97

281

12.93

13

0.6

52

2.39

121

5.57

2174

100

East

2108

55.28

887

23.26

52

1.36

66

1.73

449

11.78

17

0.45

88

2.31

146

3.83

3813

100

Central-south

1592

39.42

1153

28.55

97

2.4

243

6.02

686

16.98

19

0.47

52

1.29

197

4.88

4039

100

South-west

480

20.17

1124

47.23

137

5.76

16

0.67

151

6.34

149

6.26

91

3.82

232

9.75

2380

100

North-west

279

30.69

472

51.93

6

0.66

4

0.44

94

10.34

2

0.22

13

1.43

39

4.29

909

100

Period

1994–2005

103

19.66

89

16.98

26

4.96

1

0.19

250

47.71

22

4.2

14

2.67

19

3.63

524

100

2006–2008

679

33.68

486

24.11

103

5.11

28

1.39

602

29.86

31

1.54

38

1.88

49

2.43

2016

100

2009–2011

2423

44.23

1639

29.92

70

1.28

108

1.97

843

15.39

105

1.92

115

2.1

175

3.19

5478

100

2012–2014

2586

49.16

1424

27.07

93

1.77

149

2.83

570

10.84

55

1.05

94

1.79

289

5.49

5260

100

2015–2017

1797

46.98

1108

28.97

33

0.86

66

1.73

377

9.86

27

0.71

101

2.64

316

8.26

3825

100

2018–2020

1568

44.04

1096

30.79

32

0.9

99

2.78

235

6.6

19

0.53

137

3.85

374

10.51

3560

100

  1. MSM, men who have sex with men; URF, unique recombinant form.
  2. North, Beijing, Tianjin, Hebei, Shanxi, and Inner Mongolia. North-east, Liaoning, Jilin, and Heilongjiang. East, Shanghai, Jiangsu, Zhejiang, Anhui, Fujian, Jiangxi, and Shandong. Central- south, Henan, Hubei, Hunan, Guangdong, Guangxi, and Hainan. South-west, Chongqing, Sichuan, Guizhou, Yunnan, and Tibet. North-west, Shann'xi, Gansu, Qinghai, Ningxia, and Sinkiang.
  3. Minor, A1, D, F1, G, H, CRF02_AG, CRF03_AB, CRF06_cpx, CRF15_01B, CRF18_cpx, CRF24_BG, CRF33_01B, CRF55_01B, CRF57_BC, CRF58_01B, CRF59_01B, CRF61_BC, CRF62_BC, CRF63_02A1, CRF64_BC, CRF65_cpx, CRF67_01B, CRF68_01B, CRF78_cpx, CRF79_0107, CRF82_cpx, CRF83_cpx, CRF85_BC, CRF86_BC, CRF87_cpx, CRF88_BC, and CRF96_cpx.